BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21880514)

  • 1. MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis.
    Leite KR; Tomiyama A; Reis ST; Sousa-Canavez JM; Sañudo A; Camara-Lopes LH; Srougi M
    Urol Oncol; 2013 Aug; 31(6):796-801. PubMed ID: 21880514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.
    Leite KR; Sousa-Canavez JM; Reis ST; Tomiyama AH; Camara-Lopes LH; Sañudo A; Antunes AA; Srougi M
    Urol Oncol; 2011; 29(3):265-9. PubMed ID: 19372056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy.
    Bastacky S; Cieply K; Sherer C; Dhir R; Epstein JI
    Hum Pathol; 2004 Mar; 35(3):281-9. PubMed ID: 15017583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
    PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Kang JS; Calvo BF; Maygarden SJ; Caskey LS; Mohler JL; Ornstein DK
    Clin Cancer Res; 2002 Jan; 8(1):117-23. PubMed ID: 11801547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
    Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
    BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
    Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
    Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitable reference genes for relative quantification of miRNA expression in prostate cancer.
    Schaefer A; Jung M; Miller K; Lein M; Kristiansen G; Erbersdobler A; Jung K
    Exp Mol Med; 2010 Nov; 42(11):749-58. PubMed ID: 20890088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy.
    Zheng Q; Peskoe SB; Ribas J; Rafiqi F; Kudrolli T; Meeker AK; De Marzo AM; Platz EA; Lupold SE
    Prostate; 2014 Dec; 74(16):1655-62. PubMed ID: 25252191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial high-grade prostatic intraepithelial neoplasia with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.
    Al-Hussain TO; Epstein JI
    Am J Surg Pathol; 2011 Aug; 35(8):1165-7. PubMed ID: 21716083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma.
    Zalewski K; Misiek M; Kowalik A; Bakuła-Zalewska E; Kopczyński J; Zielińska A; Bidziński M; Radziszewski J; Góźdź S; Kowalewska M
    Tumour Biol; 2017 Nov; 39(11):1010428317717140. PubMed ID: 29299981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
    Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M
    Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR).
    Gordanpour A; Nam RK; Sugar L; Bacopulos S; Seth A
    J Vis Exp; 2012 May; (63):e3874. PubMed ID: 22643910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.
    Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z
    Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.